Targeting telomerase for cancer therapeutics
2008
Targeting Telomerase for Cancer Treatment
publication
Evidence: moderate
Author Information
Author(s): Shay J W, Keith W N
Primary Institution: University of Texas Southwestern Medical Center at Dallas
Hypothesis
Can targeting telomerase provide effective cancer therapeutics?
Conclusion
Targeting telomerase shows promise as a novel approach for cancer treatment, with several clinical trials underway.
Supporting Evidence
- Telomerase is detected in approximately 90% of all malignant tumors.
- Targeting telomerase may lead to cell death in tumors.
- Clinical trials are exploring various telomerase-targeting therapies.
Takeaway
Scientists are trying to find ways to stop cancer cells from growing by targeting a special part of the cells called telomerase, which helps them live longer.
Methodology
This review discusses various approaches to target telomerase, including gene therapy, immunotherapy, and small-molecule inhibitors.
Limitations
No gene therapy product has yet been approved for cancer treatment, and technical hurdles remain.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website